Health inspection·October 3, 2024

F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. Based on observations, facility policy review, and staff interviews, it was determined that the facility failed to store drugs used in the facility in accordance with currently accepted professional principles and the expiration dates for three of three medication carts observed (B Hall, C Hall, and G Hall medication carts). Findings Include: Review of facility policy, titled 5.3 Storage and Expiration Dating of Medications and Biologicals, last revised August 1, 2024, revealed it stated, 2. Facility should ensure that medications and biologicals are stored in an orderly manner in cabinets, drawers, carts, .3. Facility should ensure that food is not to be stored in the refrigerator, freezer, or general storage areas where medication and biologicals are stored .11. Once any medication or biological package is opened, the facility should follow manufacturer/supplier guidelines with respect to expiration dates for opened medication. Facility staff should record the date opened on the primary medication container (ie., vial, bottle, inhaler) when the medication has a shortened expiration date once opened or opened .11.3 If a multi-dose vial of an injectable medication has been opened or accessed (e.g., needle-punctured), the vial should be dated and discarded within 28 days unless the manufacturer specifies a different (shorter or longer) date for that opened vial .12. Facility should destroy and reorder medication and biologicals with soiled, illegible, worn, makeshift, incomplete, damaged, or missing labels or cautionary instructions . Observations of the G Hall medication cart on September 30, 2024, at approximately 12:00 PM, revealed the following: One insulin glargine prefilled pen that was in use with no opened date on the medication. One Lantus Solostar insulin pen with no opened date on the medication. One Admelog insulin pen with no opened date on the medication. One Lispro multidose vial of insulin with no opened date on the medication. Two Novolin 70/30 insulin multidose containers with no opened date on the medication. One prefilled insulin pen which had a sticker adhered to it that covered the name of the medication, the manufacturer's expiration date, and lot number of the medication. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 395395 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 395395 B. Wing A. Building (X3) DATE SURVEY COMPLETED 10/03/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE River's Bend Health & Rehab Center 800 King Russ Road Harrisburg, PA 17109 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)